Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Animal Genome Biotech Raises $9M in Seed Funds

Brown bear

A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds. . . . → Read More: Animal Genome Biotech Raises $9M in Seed Funds

Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Blooming cannibis plant

A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Infographic – Digital Therapeutics Funding on the Rise

Chart: digital therapeutics funding

The technology intelligence company CB Insights reported on new investments in digital therapeutics and found a record-setting funding pace this year. . . . → Read More: Infographic – Digital Therapeutics Funding on the Rise

Neuroscience Software Company Raises $23M in Early Funds

Brain circuits illustration

A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round. . . . → Read More: Neuroscience Software Company Raises $23M in Early Funds

FDA Okays One-Time HIV Treatment Clinical Trial

HIV released from cell

A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial

Trial Shows VR Training Helps Correct Lazy Eye in Kids

Child with VR headset

Clinical trial findings show a digital therapy using virtual reality headsets improves vision in children with amblyopia, or lazy eye, more than corrective lenses alone. . . . → Read More: Trial Shows VR Training Helps Correct Lazy Eye in Kids

Gene-Edited Treatments in Works for Safer Cancer Therapies

T-cells and cancer cells

A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies

Pharma, Synthetic Bio Companies to Find Antibody Therapies

DNA chip graphic

A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies

Digital Biofeedback Device Shown to Reduce PTSD

Road-side bomb

Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder. . . . → Read More: Digital Biofeedback Device Shown to Reduce PTSD

FDA Sends Warning on Covid-19 Food Therapy Trials

Gut microbes illustration

The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms. . . . → Read More: FDA Sends Warning on Covid-19 Food Therapy Trials